milnacipran and Disease Models, Animal

Topics: Animals; Brain Injuries, Traumatic; Disease Models, Animal; Executive Function; Frontal Lobe; Male; Maze Learning; Milnacipran; Rats; Rats, Sprague-Dawley

Topics: Analgesics; Animals; Anti-Inflammatory Agents; Carrageenan; Cytokines; Disease Models, Animal; Edema; Hyperalgesia; Indomethacin; Inflammation; Interleukin-1beta; Interleukin-6; Male; Malondialdehyde; Milnacipran; Nitric Oxide; Nitrosative Stress; Oxidative Stress; Pain; Peroxidase; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha

Topics: Administration, Oral; Animals; Antidepressive Agents; Depression; Disease Models, Animal; Drugs, Chinese Herbal; Gene Expression Profiling; Gene Expression Regulation; Gene Ontology; Hippocampus; Japan; Male; Medicine, Kampo; Mice; Mice, Inbred BALB C; Milnacipran; Molecular Sequence Annotation; Nerve Tissue Proteins; Oligonucleotide Array Sequence Analysis; Recurrence; Social Defeat; Stress, Psychological

Topics: Amitriptyline; Analgesics; Animals; Antidepressive Agents; Cyclopropanes; Disease Models, Animal; Dopamine; Dopamine Antagonists; Duloxetine Hydrochloride; Fluoxetine; Hyperalgesia; Male; Milnacipran; Neuralgia; Pain Threshold; Rats, Sprague-Dawley; Spinal Cord Dorsal Horn; Sulpiride

Topics: Animals; Cyclopropanes; Disease Models, Animal; Fluvoxamine; Hyperalgesia; Male; Mice; Milnacipran; Neuralgia; Paclitaxel

Topics: Analgesics; Animals; Cyclopropanes; Disease Models, Animal; Mice; Mice, Inbred BALB C; Milnacipran; Pain; Pain Measurement; Pain Threshold; Selective Serotonin Reuptake Inhibitors; Sertraline; Tail; Time Factors; Treatment Outcome

Topics: Adrenergic alpha-2 Receptor Antagonists; Analgesics; Animals; Behavior, Animal; Combined Modality Therapy; Cyclopropanes; Disease Models, Animal; Electroacupuncture; Hyperalgesia; Male; Milnacipran; Motor Activity; Neuralgia; Pain Threshold; Rats, Sprague-Dawley; Reaction Time; Serotonin and Noradrenaline Reuptake Inhibitors; Time Factors

Topics: Analysis of Variance; Animals; Antidepressive Agents; Brain; Bupropion; Chromatography, High Pressure Liquid; Cyclopropanes; Depressive Disorder; Desipramine; Disease Models, Animal; Drug Interactions; Excitatory Amino Acid Antagonists; Injections, Intraperitoneal; Male; Mice; Milnacipran; Motor Activity; Paroxetine; Piperidines; Receptors, N-Methyl-D-Aspartate

Topics: Administration, Oral; Animals; Biological Availability; Caco-2 Cells; Crystallography, X-Ray; Cyclopropanes; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Humans; Male; Microsomes, Liver; Milnacipran; Models, Molecular; Molecular Structure; Molecular Weight; Neuralgia; Norepinephrine Plasma Membrane Transport Proteins; Pain Measurement; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Spinal Nerves; Stereoisomerism; Structure-Activity Relationship

Topics: Analgesics; Animals; Antidepressive Agents; Cyclopropanes; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Fluvoxamine; Hyperalgesia; Injections, Spinal; Male; Milnacipran; Pain Threshold; Paroxetine; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Sciatic Neuropathy; Selective Serotonin Reuptake Inhibitors; Serotonin; Spinal Cord

Topics: Afferent Pathways; Analgesics; Animals; Biomarkers; Chronic Disease; Cyclopropanes; Disease Models, Animal; Gyrus Cinguli; Immunohistochemistry; Ligation; Milnacipran; Neuralgia; Nociceptors; Pain Measurement; Pain Threshold; Pain, Intractable; Peripheral Nervous System Diseases; Posterior Horn Cells; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Sciatic Neuropathy; Selective Serotonin Reuptake Inhibitors; Time Factors; Up-Regulation

Topics: Analysis of Variance; Animals; Antidepressive Agents; Anxiety Disorders; Behavior, Animal; Brain Ischemia; Cyclopropanes; Depressive Disorder; Desipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Fluvoxamine; Hippocampus; Imipramine; Immobility Response, Tonic; Male; Milnacipran; Motor Activity; Rats; Rats, Wistar

Topics: Analgesics, Opioid; Animals; Antidepressive Agents; Behavior, Animal; Cyclopropanes; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Fibromyalgia; Hydrogen-Ion Concentration; Hyperalgesia; Injections, Intraperitoneal; Male; Milnacipran; Pain; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Sodium Chloride; Time Factors; Tramadol

Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Behavior, Animal; Choice Behavior; Cyclopropanes; Disease Models, Animal; Dose-Response Relationship, Drug; Fluvoxamine; Impulsive Behavior; Male; Milnacipran; Nicotine; Nicotinic Agonists; Propylamines; Rats; Rats, Wistar; Reaction Time; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors

Topics: Animals; Bromodeoxyuridine; Cell Proliferation; Cyclopropanes; Depression; Disease Models, Animal; Drugs, Chinese Herbal; Hippocampus; Hypothalamus; Intracellular Signaling Peptides and Proteins; Magnoliopsida; Male; Medicine, Kampo; Mice; Mice, Inbred Strains; Milnacipran; Neuropeptide Y; Neuropeptides; Neurotransmitter Agents; Norepinephrine; Orexins; Phytotherapy; Selective Serotonin Reuptake Inhibitors; Serotonin; Stress, Psychological

Topics: Animals; Anticonvulsants; Brain; Cyclopropanes; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Electroshock; Male; Memory; Mice; Milnacipran; Psychomotor Performance; Seizures; Selective Serotonin Reuptake Inhibitors

Topics: Animals; Bronchodilator Agents; Cognition Disorders; Cyclopropanes; Disease Models, Animal; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Fibromyalgia; Humans; Meta-Analysis as Topic; Milnacipran; Muscle Relaxants, Central; Muscle, Skeletal; Nausea; Norepinephrine; Pain; Pain Measurement; Patient Compliance; Patient Satisfaction; Placebos; Sex Factors; Time Factors; Treatment Outcome

Topics: Animals; Behavior, Animal; Cyclopropanes; Depression; Disease Models, Animal; Escape Reaction; Fluvoxamine; Male; Maze Learning; Memory; Mice; Mice, Inbred C57BL; Milnacipran; Selective Serotonin Reuptake Inhibitors; Swimming

Topics: Amitriptyline; Analgesics; Animals; Behavior, Animal; Cold Temperature; Constriction; Cyclopropanes; Disease Models, Animal; Hyperalgesia; Milnacipran; Neuralgia; Rats; Sciatic Nerve; Time Factors

Topics: Analgesics; Animals; Antidepressive Agents; Clomipramine; Cyclopropanes; Diabetes Mellitus, Experimental; Disease Models, Animal; Duloxetine Hydrochloride; Hyperalgesia; Male; Milnacipran; Naloxone; Neuralgia; Rats; Rats, Sprague-Dawley; Thiophenes

Topics: Alcoholism; Analysis of Variance; Animals; Antidepressive Agents; Central Nervous System Depressants; Conditioning, Operant; Cyclopropanes; Desipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanol; Extinction, Psychological; Female; Fluoxetine; Locomotion; Male; Mice; Mice, Inbred DBA; Milnacipran; Rats; Rats, Wistar; Self Administration

Topics: Adrenergic Uptake Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Cyclopropanes; Disease Models, Animal; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Indomethacin; Male; Milnacipran; Rats; Rats, Wistar; Thiophenes

Topics: Abdominal Pain; Acetic Acid; Analgesics; Animals; Butyrates; Cyclopropanes; Disease Models, Animal; Drug Administration Schedule; Irritable Bowel Syndrome; Male; Mice; Milnacipran; Rats; Visceral Pain

Topics: Adrenergic Uptake Inhibitors; Animals; Cyclopropanes; Disease Models, Animal; Electric Stimulation; Evoked Potentials; Long-Term Potentiation; Male; Milnacipran; Nerve Fibers, Unmyelinated; Neuralgia; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Spinal Cord; Synaptic Transmission

Topics: Acute Disease; Amines; Amitriptyline; Animals; Conscious Sedation; Cyclohexanecarboxylic Acids; Cyclohexanols; Cyclopropanes; Disease Models, Animal; Drug Therapy, Combination; Duloxetine Hydrochloride; Fluoxetine; Formaldehyde; Gabapentin; gamma-Aminobutyric Acid; Male; Methyltyrosines; Milnacipran; Neuromuscular Junction; Norepinephrine; p-Chloroamphetamine; Pain; Paroxetine; Rats; Rats, Sprague-Dawley; Serotonin; Thiophenes; Venlafaxine Hydrochloride

Topics: Analgesics; Animals; Central Nervous System; Cyclopropanes; Disease Models, Animal; Drug Administration Schedule; Foot; Hyperalgesia; Injections, Intravenous; Injections, Spinal; Ligation; Male; Milnacipran; Pain Measurement; Pain Threshold; Peripheral Nervous System Diseases; Physical Stimulation; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Spinal Nerves; Weight-Bearing

Topics: Analgesics; Animals; Antidepressive Agents; Cyclopropanes; Disease Models, Animal; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Milnacipran; Neuritis; Spinal Cord

Topics: Animals; Crystallography, X-Ray; Disease Models, Animal; Humans; Nerve Tissue Proteins; Neurotransmitter Uptake Inhibitors; Norepinephrine; Pain; Pyrrolidines; Rats; Selective Serotonin Reuptake Inhibitors; Structure-Activity Relationship